Global Liquid Biopsy Market Size, Share, Growth & Trends Report Segmented by Technology (NGS, dPCR), Biomarker (ctDNA, cfDNA, CTCs), Application (Lung, Breast, Colorectal, Prostate, Prenatal), Sample (Blood, Urine), Product & Service, End-user, Analysis & Regional Forecast to 2031

Global Liquid Biopsy Market Segmentation This report by Medi-Tech Insights provides thesize of the global liquid biopsy market at theregional and country-level from 2024 to 2031. The report further segments the market by product & service, technology, biomarker type, sample type, application, and end user.

• Market Size & Forecast (2024-2031), By Product & Service, USD Billion
  • Kits & Reagents
  • Instruments
  • Software & Services

• Market Size & Forecast (2024-2031), By Technology, USD Billion
  • Next-Generation Sequencing (NGS)
  • PCR & Digital PCR (dPCR)
  • Others

• Market Size & Forecast (2024-2031), By Biomarker Type, USD Billion
  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (ctDNA)
  • Cell-Free DNA (cfDNA)
  • Exosomes/Microvesicles
  • Others
  • Market Size & Forecast (2024-2031), By Sample Type, USD Billion
    • Blood
    • Urine
    • Others
  • Market Size & Forecast (2024-2031), By Application, USD Billion
    • Oncology
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Prostate Cancer
      • Others
    • Non-Cancer Applications
      • Prenatal Testing
      • Transplant Monitoring
      • Infectious Diseases
      • Neurological Disorders
  • Market Size & Forecast (2024-2031), By End User, USD Billion
    • Hospitals and Laboratories
    • Specialty Clinics
    • Academic and Research Centers
    • Others
  • Market Size & Forecast (2024-2031), By Region, USD Billion
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa